Interpace Biosciences, Inc.
IDXG
$1.14
-$0.03-2.56%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 6.70M | 5.85M | 3.96M | 2.07M | 1.95M |
| Total Depreciation and Amortization | 748.00K | 723.00K | 886.00K | 1.26M | 1.60M |
| Total Amortization of Deferred Charges | -- | 0.00 | 14.00K | 28.00K | 42.00K |
| Total Other Non-Cash Items | 872.00K | 1.06M | 999.00K | 1.36M | 1.43M |
| Change in Net Operating Assets | -3.68M | -3.03M | -2.27M | -2.12M | -1.24M |
| Cash from Operations | 4.65M | 4.60M | 3.59M | 2.60M | 3.79M |
| Capital Expenditure | -876.00K | -889.00K | -519.00K | -433.00K | -470.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 500.00K | 383.00K | 383.00K |
| Cash from Investing | -876.00K | -889.00K | -19.00K | -50.00K | -87.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.60M | -4.10M | -4.10M | -2.80M | -2.50M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -46.00K | -32.00K | -32.00K | -32.00K | -32.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -161.00K | -2.50M | -2.50M | -2.50M | -2.50M |
| Cash from Financing | -5.81M | -6.63M | -6.63M | -5.33M | -5.03M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.04M | -2.92M | -3.06M | -2.78M | -1.33M |